USP9X and cancer: In addition, we demonstrated that the depletion of ZBTB38, or its regulator deubiquitinase USP9X, enhances the cytotoxicity of 5-azacytidine derivatives in different cancer and leukemia cells, which was concomitant with the enhanced expression of CDKN1C mRNA.